Pharmaceuticals (Feb 2024)

The Effect of a <i>Tribulus</i>-Based Formulation in Alleviating Cholinergic System Impairment and Scopolamine-Induced Memory Loss in Zebrafish (<i>Danio rerio</i>): Insights from Molecular Docking and In Vitro/In Vivo Approaches

  • Salwa Bouabdallah,
  • Ion Brinza,
  • Razvan Stefan Boiangiu,
  • Mona H. Ibrahim,
  • Iasmina Honceriu,
  • Amna Al-Maktoum,
  • Oana Cioanca,
  • Monica Hancianu,
  • Amr Amin,
  • Mossadok Ben-Attia,
  • Lucian Hritcu

DOI
https://doi.org/10.3390/ph17020200
Journal volume & issue
Vol. 17, no. 2
p. 200

Abstract

Read online

Tribulus terrestris L. (Tt) has been recently gaining attention for its pharmacological value, including its neuroprotective activities. In this study, we explore the neuroprotective effects of a Tribulus terrestris extract in a zebrafish (Danio rerio) model of scopolamine (SCOP)-induced memory impairment and brain oxidative stress. SCOP, an anticholinergic drug, was employed to replicate fundamental aspects of Alzheimer’s disease (AD) in animal models. The fish were treated with ethanolic leaf extract (ELE) from Tt (1, 3, and 6 mg/L) for 15 days. SCOP (100 µM) was administered 30 min before behavioral tests were conducted. Molecular interactions of the major compounds identified via UPLC-PDA/MS in Tt fractions with the active site of acetylcholinesterase (AChE) were explored via molecular docking analyses. Terrestrosin C, protodioscin, rutin, and saponin C exhibited the most stable binding. The spatial memory performance was assessed using the Y-maze test, and memory recognition was examined using a novel object recognition (NOR) test. Tt extract treatment reversed the altered locomotion patterns that were caused by SCOP administration. Biochemical analyses also verified Tt’s role in inhibiting AChE, improving antioxidant enzyme activities, and reducing oxidative stress markers. The present findings pave the way for future application of Tt as a natural alternative to treat cognitive disorders.

Keywords